 Avid Bioservices NASDAQ:CDMOs stock had its buy rating reissued by analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, TipRanks reports. They currently have a 9.00 target price on the biopharmaceutical companys stock. HC Wainwrights target price would indicate a potential upside of 37.20 from the companys previous close. ... 